This document provides a brief evaluation of the worldwide private equity investor database. Our team utilized a keyword tracking tool to identify investors who used spin-off-related terminology on their websites. As a result, we have produced a comprehensive Excel spreadsheet that can precisely identify relevant investors in the spin-off sector.
Spin-off transactions in private equity usually involve a parent company divesting a business unit or subsidiary, which then becomes an independent company. This process frequently occurs when the parent company determines that the spin-off business is outside its core operations or strategic focus. In this article, we are introducing three interesting spin-off-focused private equity funds from our keyword crawler-based spin-off-private equity investors list.
1. Trail (Paris)
Trail is a European private equity firm that has been involved in numerous significant investment and spin-off transactions. Since its establishment in 2007, Trail has managed over €850 million in cumulated capital. The firm focuses on helping small and mid-sized European companies expand, with a strong emphasis on Asia. Electropoli is a top provider of surface treatment services in Europe, particularly for the automotive industry. Trail made a significant acquisition in March 2019 by partnering with Electropoli’s management team and receiving support from China Synergy Fund, an investment platform established by CICC, China’s leading investment bank and private equity manager.
2. JEITO (Paris)
Jeito Capital is a private equity firm based in Paris that specializes in biotech and biopharma. The company finances and accelerates the development of innovative medical technologies, with a focus on building market leaders in various therapeutic areas. Jeito Capital has been involved in several notable spin-off-related transactions and investments, including SparingVision. Jeito Capital co-led a €75 million Series B financing round for SparingVision, a company that develops genomic medicines to treat inherited retinal diseases.
3. Essling Capital (Paris)
Essling Capital is a private equity firm based in Paris that specializes in unlisted assets. Launched in 2017 as a spin-off of Massena Partners’ private equity business, the company operates in various areas of private equity. This includes co-investment in Europe and the United States, as well as lead investment in small and mid-cap. Essling Capital particularly targets high-growth companies in the digital, healthcare, and B2B services sectors. Essling Capital was involved in the acquisition of Altair in 2020, a secondary sale transaction in France. Furthermore, Essling Expansion, the firm’s lead small-cap investment fund, announced the sale of the Evolucare Group.
Picture Source: Unsplash